Grupo Zendal | Prensa

El Grupo Zendal

Zendal Portugal

Biofarmacéuticos

NOTICIA

13 · 07 · 2023

Germany issues award to IAVI to support development of the MTBVAC tuberculosis vaccine candidate

Contacto de prensa

13 · 07 · 2023Germany issues award to IAVI to support development of the MTBVAC tuberculosis vaccine candidate

03 · 07 · 2023Zendal and Reig Jofre appointed by the EU to ensure vaccine production capacity in Europe in case of future health emergencies

29 · 06 · 2023 First annual project meeting

16 · 06 · 2023Zendal holds in Porriño a meeting of its innovation centres

01 · 06 · 2023Zendal Group announces the 4th edition of its awards aimed at recognising human and animal health projects

19 · 05 · 2023Spanish biotech Zendal and IAVI announce expanded agreement to partner on development of TB vaccine candidate MTBVAC

05 · 05 · 2023FEUGA holds the Governing Board in Zendal

18 · 04 · 2023Zendal holds an integration day with the recently acquired Laboratorios Maymó

01 · 03 · 2023The Zendal Group acquires 100% of Maymo and strengthens its expansion plan

13 · 02 · 2023Zendal Group promotes the incorporation of female talent

19 · 01 · 2023The CSIC and Zendal develop a new vaccine against canine leishmaniasis

29 · 09 · 2022The Zendal Group strengthens the management organization chart with new incorporations and an eye focused on the growth plan